Organogenesis Holdings Inc.
ORGO
$4.88
$0.214.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.29% | 1.34% | -1.96% | -5.62% | -3.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.29% | 1.34% | -1.96% | -5.62% | -3.94% |
| Cost of Revenue | 8.70% | 6.27% | 4.94% | 1.90% | 1.39% |
| Gross Profit | 12.14% | -0.18% | -4.04% | -7.88% | -5.56% |
| SG&A Expenses | 10.74% | -0.26% | -6.45% | -8.52% | -5.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.49% | 2.88% | -1.36% | -4.35% | -2.46% |
| Operating Income | 31.85% | -34.85% | -17.47% | -31.78% | -30.77% |
| Income Before Tax | -127.01% | -170.94% | -189.83% | -35.38% | -48.76% |
| Income Tax Expenses | -167.34% | -194.12% | -21.66% | 59.57% | 14.67% |
| Earnings from Continuing Operations | -82.59% | -156.77% | -264.65% | -56.85% | -68.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.59% | -156.77% | -264.65% | -56.85% | -68.16% |
| EBIT | 31.85% | -34.85% | -17.47% | -31.78% | -30.77% |
| EBITDA | 21.64% | -10.83% | 1.46% | -10.32% | -7.62% |
| EPS Basic | -116.45% | -156.25% | -262.58% | -57.18% | -68.37% |
| Normalized Basic EPS | 41.04% | -41.85% | -22.42% | -35.87% | -34.78% |
| EPS Diluted | -160.12% | -167.97% | -276.25% | -65.57% | -71.54% |
| Normalized Diluted EPS | 41.78% | -41.27% | -22.18% | -35.92% | -34.81% |
| Average Basic Shares Outstanding | 0.40% | 0.63% | 0.47% | 0.54% | 0.84% |
| Average Diluted Shares Outstanding | 0.21% | 0.15% | 0.28% | 0.46% | 0.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |